AS

Aakash Shah

Active Director Director DIN 11834379
DIN 11834379 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Aakash Shah

Aakash Shah is a Director at Crittherbs Pharma Private Limited (since 2026).

DIN 11834379
Primary Designation Director
First Appointment 17 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crittherbs Pharma Private Limited U21000GJ2026PTC180864
Director17 Jul 20262026Active

Board colleagues of Aakash Shah

NameDINCompanyDesignation
Aalap Ashokbhai Shah11834378Crittherbs Pharma Private LimitedDirector
Brijesh Bhupendra Patel09623771Crittherbs Pharma Private LimitedIndividual Subscriber
Chintan Ashokkumar ShahCrittherbs Pharma Private LimitedIndividual Subscriber
Viral Pradipbhai ShahCrittherbs Pharma Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Crittherbs Pharma Private Limited
Premium access

Shareholding and investment profile for Aakash Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aakash Shah

Aakash Shah currently holds 1 directorship: Crittherbs Pharma Private Limited (Director, since 17 Jul 2026).

Aakash Shah was first appointed on 17 Jul 2026 as Director at Crittherbs Pharma Private Limited.

The current boards of Aakash Shah's companies include Aalap Ashokbhai Shah (Crittherbs Pharma Private Limited), Brijesh Bhupendra Patel (Crittherbs Pharma Private Limited), Chintan Ashokkumar Shah (Crittherbs Pharma Private Limited), Viral Pradipbhai Shah (Crittherbs Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available